Editas Medicine Inc. Revenue 2016–2025
Editas Medicine Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Editas Medicine Inc. revenue for the quarter ending March 31, 2026 was 2.8 M, a 39.22% decrease year-over-year.
- Editas Medicine Inc. revenue for the twelve months ending March 31, 2026 was 18.6 M, a 164.16% increase year-over-year.
- Editas Medicine Inc. annual revenue for 2025 was 40.5 M, a 25.39% increase from 2024.
- Editas Medicine Inc. annual revenue for 2024 was 32.3 M, a 58.64% decrease from 2023.
- Editas Medicine Inc. annual revenue for 2023 was 78.1 M, a 296.32% increase from 2022.
- Editas Medicine Inc. annual revenue for 2022 was 19.7 M.
Editas Medicine Inc. (EDIT) — Frequently Asked Questions
Editas Medicine Inc. (EDIT) is a publicly traded US company. It has a market capitalization of $220M. In fiscal 2025 it reported revenue of $41M and net income of -$160M. Explore EDIT's stock price, financial statements, earnings history, margins and key ratios below.
What is Editas Medicine Inc.'s market cap?
Editas Medicine Inc. (EDIT) has a market capitalization of $220M.
What is the EDIT stock price?
EDIT trades at $2.48 (-6.42% on the day).
How much revenue does Editas Medicine Inc. make?
Editas Medicine Inc. reported revenue of $41M in fiscal 2025.
Is EDIT profitable?
In fiscal 2025, Editas Medicine Inc. reported net income of -$160M.